A Conversation with Parminder Bhatia, Chief AI Officer, GE HealthCare After three episodes with leaders in oncology and medicine - Prof. Malapelle (International Society of Liquid Biopsy), Dr. David Rhew (Microsoft), and Dr. Pedram Razavi (MSK), Jurgi turns to the question everyone’s asking: How do we move from impressive demos to real impact at the bedside—at scale? In this episode, Dr. Jurgi Camblong, Founder SOPHiA GENETICS, speaks with Parminder “Parry” Bhatia, Chief AI Officer at GE ...
All content for Decoded is the property of Dr. Jurgi Camblong and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A Conversation with Parminder Bhatia, Chief AI Officer, GE HealthCare After three episodes with leaders in oncology and medicine - Prof. Malapelle (International Society of Liquid Biopsy), Dr. David Rhew (Microsoft), and Dr. Pedram Razavi (MSK), Jurgi turns to the question everyone’s asking: How do we move from impressive demos to real impact at the bedside—at scale? In this episode, Dr. Jurgi Camblong, Founder SOPHiA GENETICS, speaks with Parminder “Parry” Bhatia, Chief AI Officer at GE ...
Liquid Biopsy Decoded: Data, Diagnostics, and the Future of Cancer Care
Decoded
23 minutes
4 months ago
Liquid Biopsy Decoded: Data, Diagnostics, and the Future of Cancer Care
How do we move from discovery to action in the fight against cancer? In this inaugural episode of the Decoded podcast, Dr. Jurgi Camblong speaks with Professor Umberto Malapelle, one of the leading voices in molecular diagnostics and liquid biopsy, to explore how precision data is reshaping the fight against cancer. Together, they decode the evolving role of pathology, tracing the shift from glass slides to genomic signals and the rise of liquid biopsy as a dynamic, non-invasive tool in ca...
Decoded
A Conversation with Parminder Bhatia, Chief AI Officer, GE HealthCare After three episodes with leaders in oncology and medicine - Prof. Malapelle (International Society of Liquid Biopsy), Dr. David Rhew (Microsoft), and Dr. Pedram Razavi (MSK), Jurgi turns to the question everyone’s asking: How do we move from impressive demos to real impact at the bedside—at scale? In this episode, Dr. Jurgi Camblong, Founder SOPHiA GENETICS, speaks with Parminder “Parry” Bhatia, Chief AI Officer at GE ...
